Pharmacoepidemiology and Drug Safety
© John Wiley & Sons Ltd
Edited By: B.L. Strom, USA; S. Hennessy, USA; H. G. M. Leufkens, The Netherlands; B.J. Park, Korea
Impact Factor: 2.908
ISI Journal Citation Reports © Ranking: 2015: 81/253 (Pharmacology & Pharmacy)
Online ISSN: 1099-1557
Recently Published Issues
PDS is the Official Journal of the International Society for Pharmacoepidemiology (ISPE)
Members receive online access to the journal here.
Join ISPE today to gain journal access tomorrow.
Time from Submission to First Decision
Pharmacoepidemiology and Drug Safety provides authors with a fast decision process. In 2014, Pharmacoepidemiology and Drug Safety had an average time from submission to first decision of 40 days.
Ronald D. Mann Best Paper Award
Many congratulations to the Ronald D. Mann Best Paper Award finalists for the best articles published in the 2015 Volume.
Use of macrolides during pregnancy and the risk of birth defects: a population-based study
Anick Bérard, Odile Sheehy, et al.
Estimating the number of sudden cardiac deaths attributable to the use of domperidone in France
Catherine Hill, Philippe Nicot, et al.
The ecology of prescription opioid abuse in the USA: geographic variation in patients' use of multiple prescribers (“doctor shopping”)
Douglas C. McDonald and Kenneth E. Carlson
Most Cited Articles
Top cited articles published in 2014 – 2015 from Pharmacoepidemiology and Drug Safety
Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population
Yingjun Zhou, Denise M. Boudreau, et al.
Post-licensure safety surveillance for human papillomavirus-16/18-AS04-adjuvanted vaccine: more than 4 years of experience
Maria-Genalin Angelo, Julia Zima, et al.
Pooled analysis of large and long-term safety data from the human papillomavirus-16/18-AS04-adjuvanted vaccine clinical trial programme
Maria-Genalin Angelo, Marie-Pierre David, et al.
Reductions in prescription opioid diversion following recent legislative interventions in Florida
Hilary L. Surratt, Catherine O'Grady, et al.
Reductions in reported deaths following the introduction of extended-release oxycodone (OxyContin) with an abuse-deterrent formulation
Nelson E. Sessler, Jerod M. Downing, et al.